HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Peter L Collins Selected Research

Antiviral Agents (Antivirals)

1/2020Human parainfluenza virus type 3 expressing the respiratory syncytial virus pre-fusion F protein modified for virion packaging yields protective intranasal vaccine candidates.
1/2019The alpha-1 subunit of the Na+,K+-ATPase (ATP1A1) is required for macropinocytic entry of respiratory syncytial virus (RSV) in human respiratory epithelial cells.
1/2018Differential Responses by Human Respiratory Epithelial Cell Lines to Respiratory Syncytial Virus Reflect Distinct Patterns of Infection Control.
1/2017Improved Prefusion Stability, Optimized Codon Usage, and Augmented Virion Packaging Enhance the Immunogenicity of Respiratory Syncytial Virus Fusion Protein in a Vectored-Vaccine Candidate.
12/2007Influence of a single viral epitope on T cell response and disease after infection of mice with respiratory syncytial virus.
9/2007RSV604, a novel inhibitor of respiratory syncytial virus replication.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Peter L Collins Research Topics

Disease

45Infections
12/2020 - 02/2002
23Paramyxoviridae Infections (Parainfluenza)
12/2020 - 07/2002
22Respiratory Syncytial Virus Infections
07/2023 - 09/2003
10Virus Diseases (Viral Diseases)
01/2017 - 05/2002
7Respiratory Tract Diseases (Respiratory Tract Disease)
01/2017 - 02/2002
6Fever (Fevers)
11/2018 - 03/2006
5Respiratory Tract Infections (Respiratory Tract Infection)
01/2019 - 05/2005
5Inflammation (Inflammations)
06/2014 - 06/2005
4Pneumonia (Pneumonitis)
01/2024 - 08/2005
4Influenza in Birds (Avian Flu)
03/2010 - 11/2007
3Bronchiolitis
01/2024 - 11/2016
3Alcoholic Hepatitis
12/2019 - 03/2015
3Newcastle Disease
03/2013 - 03/2010
2Lung Diseases (Lung Disease)
01/2017 - 06/2014
2Reinfection
04/2013 - 04/2010
2Bacterial Infections (Bacterial Infection)
07/2011 - 10/2005
2Cystic Fibrosis (Mucoviscidosis)
08/2010 - 10/2005
2Weight Loss (Weight Reduction)
05/2010 - 12/2007
2Severe Acute Respiratory Syndrome
06/2007 - 06/2004
2Human Influenza (Influenza)
01/2005 - 12/2002
1Rhinorrhea
07/2023
1Respiratory Sounds (Crackle)
11/2018
1End Stage Liver Disease
03/2017
1Asthma (Bronchial Asthma)
01/2016
1Rheumatoid Arthritis
01/2016
1Venezuelan Equine Encephalomyelitis
08/2015
1Cytokine Release Syndrome
06/2014
1Airway Obstruction (Choking)
05/2014
1Necrosis
09/2013
1Acquired Immunodeficiency Syndrome (AIDS)
01/2013
1Lyme Disease (Disease, Lyme)
07/2011
1Coinfection
05/2010
1Latent Infection
04/2010
1Respiratory Hypersensitivity
05/2009
1Emerging Communicable Diseases (Emerging Infectious Diseases)
02/2008
1Viremia
03/2006

Drug/Important Bio-Agent (IBA)

46VaccinesIBA
01/2024 - 02/2002
19Proteins (Proteins, Gene)FDA Link
12/2020 - 09/2003
12CytokinesIBA
11/2019 - 06/2004
9Glycoproteins (Glycoprotein)IBA
01/2019 - 06/2005
9AntigensIBA
07/2011 - 02/2002
7Neutralizing AntibodiesIBA
07/2023 - 02/2002
6InterferonsIBA
07/2023 - 05/2012
6Antiviral Agents (Antivirals)IBA
01/2020 - 09/2007
4AntibodiesIBA
12/2020 - 06/2004
4EpitopesIBA
10/2010 - 06/2004
3GTP-Binding Proteins (G-Protein)IBA
01/2019 - 03/2002
3Interferon Type IIBA
05/2012 - 03/2006
3Interleukin-4 (Interleukin 4)IBA
05/2010 - 08/2005
3Attenuated VaccinesIBA
11/2005 - 12/2002
2Respiratory Syncytial Virus VaccinesIBA
07/2023 - 10/2007
2SteroidsIBA
03/2017 - 03/2015
2Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
06/2014 - 09/2003
2Interferon-gamma (Interferon, gamma)IBA
06/2014 - 12/2007
2MucinsIBA
09/2013 - 05/2009
2Interleukin-13IBA
09/2013 - 05/2009
2Membrane Glycoproteins (Membrane Glycoprotein)IBA
01/2013 - 06/2007
2N-Acetylneuraminic Acid (Sialic Acid)IBA
12/2011 - 01/2005
2Cystic Fibrosis Transmembrane Conductance Regulator (Protein, CFTR)IBA
12/2010 - 08/2010
2Phenobarbital (Luminal)FDA Link
08/2010 - 12/2005
2Membrane Proteins (Integral Membrane Proteins)IBA
03/2010 - 01/2009
2Neuraminidase (Sialidase)IBA
02/2010 - 01/2005
2Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA
06/2007 - 12/2002
1Interleukin-17 (Interleukin 17)IBA
12/2019
1Green Fluorescent ProteinsIBA
01/2019
1Complement System Proteins (Complement)IBA
01/2019
1Pattern Recognition ReceptorsIBA
01/2018
1Actins (F Actin)IBA
09/2017
1CreatinineIBA
03/2017
1Adrenal Cortex Hormones (Corticosteroids)IBA
03/2017
1Actin-Related Protein 2IBA
12/2016
1Small Interfering RNA (siRNA)IBA
12/2016
1GlucocorticoidsIBA
01/2016
1Sphingosine-1-Phosphate ReceptorsIBA
06/2014
1sphingosine 1-phosphate (sphingosine-1-phosphate)IBA
06/2014
1Peptide Elongation Factors (Elongation Factor)IBA
02/2013
1Superoxide DismutaseIBA
05/2012
1CholesterolIBA
02/2012
1Coloring Agents (Dyes)IBA
02/2012
1Fetal Proteins (Fetoprotein)IBA
12/2010
1Chloride Channels (Chloride Channel)IBA
08/2010
1Messenger RNA (mRNA)IBA
04/2010
1Interleukin-18 (Interleukin 18)IBA
04/2010
1Hemagglutinins (Hemagglutinin)IBA
02/2010
1avian influenza A virus hemagglutininIBA
08/2009
1A-factor (Streptomyces)IBA
05/2009
1Interferon-alpha (Interferon Alfa)IBA
05/2009
1LipopolysaccharidesIBA
03/2009
1Interferon-betaIBA
02/2009
1Viral AntigensIBA
09/2008
1Caspase 3 (Caspase-3)IBA
09/2008
1T-Lymphocyte Epitopes (Epitopes, T Lymphocyte)IBA
12/2007
1Nucleocapsid ProteinsIBA
06/2007
1Cysteine (L-Cysteine)FDA Link
06/2006
1Immune Sera (Antisera)IBA
12/2005
1HN ProteinIBA
11/2005
1Adenosine (Adenocard)FDA LinkGeneric
10/2005
1Adenosine Triphosphate (ATP)IBA
10/2005

Therapy/Procedure

2Therapeutics
06/2014 - 10/2012
1Intraperitoneal Injections
03/2006